Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility
Merger includes C$20 million investment to accelerate access to genomics-based testing for cancer treatment by…
Merger includes C$20 million investment to accelerate access to genomics-based testing for cancer treatment by…
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
The latest release of Ballerina open-source language extends unique ability to simultaneously code using text…
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Company to host conference call and webcast at 3 p.m. PT on Tuesday, February 15,…
BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
• FDA Agreed to PolyPid Request for the Addition of an Unblinded Interim Analysis in…
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
– In vitro studies indicate IGM-6268 exhibits potent neutralization activity against the Omicron variant and all other…
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited…
11th Largest Craft Brewer in the U.S., SweetWater, Launches Partnership with the Country’s Largest Beer…
NEW YORK and VIENNA, Austria, Feb. 09, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
— Phase 1/2 ABILITY study of MDNA11 on track with first set of efficacy results…
–FC2 Prescription Business Entering 6th Year of Growth — –FDA Approves Company’s ENTADFI™, New Treatment…
MELBOURNE, Australia, Feb. 09, 2022 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage…
Releases three new products with industry-leading features, fueled by investments in R&D and strong global…
Vancouver, British Columbia–(Newsfile Corp. – February 9, 2022) – Abner Labs announces that it has…